David Lyth Email

Senior Medicinal Chemist . INFEX Therapeutics

Current Roles

Employees:
28
Revenue:
$4.3M
About
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.
INFEX Therapeutics Address

Alderley Edge, null
UK
INFEX Therapeutics Email